SCHEMBL23880322

SCHEMBL23880322

COc1cc2nccc(Oc3ccc(C4(C(N)=O)CC4)cc3)c2cc1OC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRA P16234 9/20 0.60
▸ PDGFRB P09619 1/20 0.60
▸ AURKB Q96GD4 3/20 0.59
▸ FLT3 P36888 2/20 0.59
▸ KDR P35968 9/20 0.58
▸ MET P08581 3/20 0.57
▸ AURKA O14965 2/20 0.57
▸ ABL1 P00519 2/20 0.57
▸ LCK P06239 2/20 0.57
▸ LYN P07948 2/20 0.57
▸ TEK Q02763 2/20 0.57
▸ KIT P10721 2/20 0.57
▸ AXL P30530 2/20 0.57
▸ RIPK2 O43353 1/20 0.57
▸ ABCB11 O95342 1/20 0.57
▸ EGFR P00533 1/20 0.57
▸ ERBB2 P04626 1/20 0.57
▸ NTRK1 P04629 1/20 0.57
▸ PGR P06401 1/20 0.57
▸ RET P07949 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3794599 0.81 FGFR2 (0.69) PDGFRAPDGFRBAURKBKDRMET
SCHEMBL23923068 0.81 PDGFRA (0.69) PDGFRAPDGFRBAURKBKDRMET
SCHEMBL29973365 0.81 PDGFRA (0.62) PDGFRAPDGFRBAURKBFLT3KDR
SCHEMBL28374301 0.81 FLT3 (0.60) PDGFRAPDGFRBAURKBFLT3KDR
SCHEMBL15509288 0.80 AURKB (0.83) PDGFRAAURKBFLT3KDRMET
SCHEMBL28378727 0.80 PDGFRA (0.57) PDGFRAPDGFRBAURKBFLT3KDR
SCHEMBL14808762 0.80 AURKB (0.67) PDGFRAPDGFRBAURKBFLT3KDR
SCHEMBL6228087 0.78 PDGFRA (0.79) PDGFRAAURKBFLT3KDRMET
SCHEMBL7486400 0.78 FGFR2 (0.84) PDGFRAPDGFRBKDREGFRFGFR2
SCHEMBL7485158 0.77 FGFR2 (0.71) PDGFRAPDGFRBAURKBFLT3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391789-A1 BICYCLIC COMPOUNDS AS KINASE MODULATORS, METHODS AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-12-07 — — US disclosed
US-11702425-B2 Bicyclic compounds as kinase modulators, methods and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-07-18 — — US disclosed
US-20210309668-A1 BICYCLIC COMPOUNDS AS KINASE MODULATORS, METHODS AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2021-10-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702425-B2 Bicyclic compounds as kinase modulators, methods and uses thereof HCCS, PRKAA1, PRKAA2 PDGFRA 1331/4885PDGFRB 1041/4885AURKB 158/4885
US-20230391789-A1 BICYCLIC COMPOUNDS AS KINASE MODULATORS, METHODS AND USES THEREOF HCCS, PRKAA1, PRKAA2 PDGFRA 1331/4885PDGFRB 1041/4885AURKB 158/4885
US-20210309668-A1 BICYCLIC COMPOUNDS AS KINASE MODULATORS, METHODS AND USES THEREOF HCCS, PRKAA1, PRKAA2 PDGFRA 1331/4885PDGFRB 1041/4885AURKB 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback